{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:24:53Z","timestamp":1778768693378,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K11555"],"award-info":[{"award-number":["24K11555"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23H03835"],"award-info":[{"award-number":["23H03835"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K27376"],"award-info":[{"award-number":["23K27376"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Accumulating evidence suggests that mitogenic signaling during cell cycle arrest can lead to severe cytotoxic outcomes, such as senescence, though the underlying mechanisms remain poorly understood. Here, we explored the link between cell cycle dynamics and the formation of PML-nuclear bodies (PML-NBs), intranuclear structures known to mediate cellular stress responses. Our findings demonstrate that PML-NBs increase their number during interphase arrest. Moreover, the activation of mitogenic ERK signaling by all-trans retinoic acid (ATRA) during CDK4\/6 inhibitor-induced cell cycle arrest synergistically enhances the formation of larger PML-NBs by associating with SUMO. This enlargement, triggered by the simultaneous engagement of opposing cell cycle signals, leads to potent cytotoxicity accompanied by either terminal differentiation or apoptosis, depending on the cell type, across multiple acute myeloid leukemia (AML) cell lines. Importantly, in an AML mouse model, this combination treatment significantly improved therapeutic efficacy with minimal effects on normal hematopoiesis. Our results introduce conflicting cell cycle signal-induced cytotoxicity as a promising therapeutic strategy for AML.<\/jats:p>","DOI":"10.1038\/s41419-025-07911-7","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:43:28Z","timestamp":1754145808000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Enlarged PML-nuclear bodies trigger conflicting cell cycle signal-mediated cytotoxicity in leukemia cells"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2161-2087","authenticated-orcid":false,"given":"Tomohisa","family":"Baba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3492-117X","authenticated-orcid":false,"given":"Soichiro","family":"Kumamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7784-5589","authenticated-orcid":false,"given":"Yuta","family":"Moriguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1081-0130","authenticated-orcid":false,"given":"Soji","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7818-8240","authenticated-orcid":false,"given":"Atsushi","family":"Hirao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6812-9607","authenticated-orcid":false,"given":"Yoshikazu","family":"Johmura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"key":"7911_CR1","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1080\/15384101.2022.2054636","volume":"21","author":"MV Blagosklonny","year":"2022","unstructured":"Blagosklonny MV. Cell senescence, rapamycin and hyperfunction theory of aging. Cell Cycle. 2022;21:1456\u201367.","journal-title":"Cell Cycle"},{"key":"7911_CR2","doi-asserted-by":"publisher","first-page":"11890","DOI":"10.1093\/nar\/gkaa828","volume":"48","author":"A Corpet","year":"2020","unstructured":"Corpet A, Kleijwegt C, Roubille S, Juillard F, Jacquet K, Texier P, et al. PML nuclear bodies and chromatin dynamics: catch me if you can!. Nucleic Acids Res. 2020;48:11890\u2013912.","journal-title":"Nucleic Acids Res"},{"key":"7911_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0092-8674(02)00626-8","volume":"108","author":"P Salomoni","year":"2002","unstructured":"Salomoni P, Pandolfi PP. The role of PML in tumor suppression. Cell. 2002;108:165\u201370.","journal-title":"Cell"},{"key":"7911_CR4","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1101\/gad.14.16.2015","volume":"14","author":"G Ferbeyre","year":"2000","unstructured":"Ferbeyre G, de Stanchina E, Querido E, Baptiste N, Prives C, Lowe SW. PML is induced by oncogenic Ras and promotes premature senescence. Genes Dev. 2000;14:2015\u201327.","journal-title":"Genes Dev"},{"key":"7911_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/35018127","volume":"406","author":"M Pearson","year":"2000","unstructured":"Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, et al. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature. 2000;406:207\u201310.","journal-title":"Nature"},{"key":"7911_CR6","doi-asserted-by":"crossref","unstructured":"Lang A, Lang E, Boe S.O. PML Bodies in Mitosis. Cells. 2019;8:893.","DOI":"10.3390\/cells8080893"},{"key":"7911_CR7","first-page":"26","volume":"106","author":"V Madan","year":"2021","unstructured":"Madan V, Koeffler HP. Differentiation therapy of myeloid leukemia: four decades of development. Haematologica. 2021;106:26\u201338.","journal-title":"Haematologica"},{"key":"7911_CR8","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1046\/j.1365-2141.1999.01501.x","volume":"106","author":"D Grimwade","year":"1999","unstructured":"Grimwade D. The pathogenesis of acute promyelocytic leukaemia: evaluation of the role of molecular diagnosis and monitoring in the management of the disease. Br J Haematol. 1999;106:591\u2013613.","journal-title":"Br J Haematol"},{"key":"7911_CR9","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0092-8674(93)80044-F","volume":"74","author":"F Grignani","year":"1993","unstructured":"Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, et al. The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell. 1993;74:423\u201331.","journal-title":"Cell"},{"key":"7911_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1062524","volume":"12","author":"SG Iyer","year":"2022","unstructured":"Iyer SG, Elias L, Stanchina M, Watts J. The treatment of acute promyelocytic leukemia in 2023: paradigm, advances, and future directions. Front Oncol. 2022;12:1062524.","journal-title":"Front Oncol"},{"key":"7911_CR11","doi-asserted-by":"crossref","unstructured":"Bercier P, de The H. History of developing acute promyelocytic leukemia treatment and role of promyelocytic leukemia bodies. Cancers (Basel). 2024;16:1351.","DOI":"10.3390\/cancers16071351"},{"key":"7911_CR12","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/nm.1891","volume":"14","author":"R Nasr","year":"2008","unstructured":"Nasr R, Guillemin MC, Ferhi O, Soilihi H, Peres L, Berthier C, et al. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation. Nat Med. 2008;14:1333\u201342.","journal-title":"Nat Med"},{"key":"7911_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nm.3441","volume":"20","author":"J Ablain","year":"2014","unstructured":"Ablain J, Rice K, Soilihi H, de Reynies A, Minucci S, de TheH. Activation of a promyelocytic leukemia-tumor protein 53 axis underlies acute promyelocytic leukemia cure. Nat Med. 2014;20:167\u201374.","journal-title":"Nat Med"},{"key":"7911_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/sj.thj.6200141","volume":"3","author":"A Belhabri","year":"2002","unstructured":"Belhabri A, Thomas X, Wattel E, Chelghoum Y, Anglaret B, Vekhoff A, et al. All trans retinoic acid in combination with intermediate-dose cytarabine and idarubicin in patients with relapsed or refractory non promyelocytic acute myeloid leukemia: a phase II randomized trial. Hematol J. 2002;3:49\u201355.","journal-title":"Hematol J"},{"key":"7911_CR15","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1182\/blood-2009-08-236588","volume":"115","author":"AK Burnett","year":"2010","unstructured":"Burnett AK, Hills RK, Green C, Jenkinson S, Koo K, Patel Y, et al. The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA. Blood. 2010;115:948\u201356.","journal-title":"Blood"},{"key":"7911_CR16","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1182\/blood.V93.8.2478","volume":"93","author":"EH Estey","year":"1999","unstructured":"Estey EH, Thall PF, Pierce S, Cortes J, Beran M, Kantarjian H, et al. Randomized phase II study of fludarabine + cytosine arabinoside + idarubicin +\/- all-trans retinoic acid +\/- granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome. Blood. 1999;93:2478\u201384.","journal-title":"Blood"},{"key":"7911_CR17","doi-asserted-by":"publisher","first-page":"4614","DOI":"10.1182\/blood-2005-10-4202","volume":"107","author":"DW Milligan","year":"2006","unstructured":"Milligan DW, Wheatley K, Littlewood T, Craig JI, Burnett AK. Group NHOCS. Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial. Blood. 2006;107:4614\u201322.","journal-title":"Blood"},{"key":"7911_CR18","doi-asserted-by":"crossref","unstructured":"Skopek R, Palusinska M, Kaczor-Keller K, Pingwara R, Papierniak-Wygladala A, Schenk T, et al. Choosing the right cell line for acute myeloid leukemia (AML) Research. Int J Mol Sci. 2023;24:5377.","DOI":"10.3390\/ijms24065377"},{"key":"7911_CR19","first-page":"1817","volume":"7","author":"ZB Hu","year":"1993","unstructured":"Hu ZB, Ma W, Uphoff CC, Lanotte M, Drexler HG. Modulation of gene expression in the acute promyelocytic leukemia cell line NB4. Leukemia. 1993;7:1817\u201323.","journal-title":"Leukemia"},{"key":"7911_CR20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1182\/blood.V95.2.535","volume":"95","author":"E Todisco","year":"2000","unstructured":"Todisco E, Suzuki T, Srivannaboon K, Coustan-Smith E, Raimondi SC, Behm FG, et al. CD38 ligation inhibits normal and leukemic myelopoiesis. Blood. 2000;95:535\u201342.","journal-title":"Blood"},{"key":"7911_CR21","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1158\/2767-9764.CRC-23-0507","volume":"4","author":"T Baba","year":"2024","unstructured":"Baba T, Tomaru U, Hirao A, Mukaida N, Johmura Y. Autophagy inhibition-induced cytosolic DNA sensing combined with differentiation therapy induces irreversible myeloid differentiation in leukemia cells. Cancer Res Commun. 2024;4:849\u201360.","journal-title":"Cancer Res Commun"},{"key":"7911_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1470-2045(15)00613-0","volume":"17","author":"M Cristofanilli","year":"2016","unstructured":"Cristofanilli M, Turner NC, Bondarenko I, Ro J, Im SA, Masuda N, et al. Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial. Lancet Oncol. 2016;17:425\u201339.","journal-title":"Lancet Oncol"},{"key":"7911_CR23","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1158\/1535-7163.MCT-23-0528","volume":"23","author":"L Hu","year":"2024","unstructured":"Hu L, Li Q, Wang J, Wang H, Ren X, Huang K, et al. The CDK4\/6 inhibitor palbociclib synergizes with ATRA to induce differentiation in AML. Mol Cancer Ther. 2024;23:961\u201372.","journal-title":"Mol Cancer Ther"},{"key":"7911_CR24","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.tibs.2022.12.003","volume":"48","author":"X Cheng","year":"2023","unstructured":"Cheng X. Protein SUMOylation and phase separation: partners in stress?. Trends Biochem Sci. 2023;48:417\u20139.","journal-title":"Trends Biochem Sci"},{"key":"7911_CR25","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00204-021-03195-w","volume":"96","author":"S Hirano","year":"2022","unstructured":"Hirano S, Udagawa O. SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells. Arch Toxicol. 2022;96:545\u201358.","journal-title":"Arch Toxicol"},{"key":"7911_CR26","doi-asserted-by":"crossref","unstructured":"Cermakova K, Hodges HC. Next-generation drugs and probes for chromatin biology: from targeted protein degradation to phase separation. Molecules. 2018;23:1958.","DOI":"10.3390\/molecules23081958"},{"key":"7911_CR27","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S1535-6108(04)00082-0","volume":"5","author":"F Hayakawa","year":"2004","unstructured":"Hayakawa F, Privalsky ML. Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis. Cancer Cell. 2004;5:389\u2013401.","journal-title":"Cancer Cell"},{"key":"7911_CR28","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S0960-9822(07)00485-X","volume":"8","author":"MJ Robinson","year":"1998","unstructured":"Robinson MJ, Stippec SA, Goldsmith E, White MA, Cobb MH. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr Biol. 1998;8:1141\u201350.","journal-title":"Curr Biol"},{"key":"7911_CR29","doi-asserted-by":"publisher","first-page":"12133","DOI":"10.1073\/pnas.1412944111","volume":"111","author":"K Korf","year":"2014","unstructured":"Korf K, Wodrich H, Haschke A, Ocampo C, Harder L, Gieseke F, et al. The PML domain of PML-RARalpha blocks senescence to promote leukemia. Proc Natl Acad Sci USA. 2014;111:12133\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7911_CR30","doi-asserted-by":"publisher","first-page":"602","DOI":"10.18632\/aging.101194","volume":"9","author":"D Bano","year":"2017","unstructured":"Bano D, Piazzesi A, Salomoni P, Nicotera P. The histone variant H3.3 claims its place in the crowded scene of epigenetics. Aging (Albany NY). 2017;9:602\u201314.","journal-title":"Aging (Albany NY)"},{"key":"7911_CR31","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1073\/pnas.82.3.790","volume":"82","author":"D Wolf","year":"1985","unstructured":"Wolf D, Rotter V. Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc Natl Acad Sci USA. 1985;82:790\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7911_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-90500-3","volume":"11","author":"E Haines","year":"2021","unstructured":"Haines E, Nishida Y, Carr MI, Montoya RH, Ostermann LB, Zhang W, et al. DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemia. Sci Rep. 2021;11:12148.","journal-title":"Sci Rep"},{"key":"7911_CR33","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1084\/jem.20130428","volume":"211","author":"R Gazit","year":"2014","unstructured":"Gazit R, Mandal PK, Ebina W, Ben-Zvi A, Nombela-Arrieta C, Silberstein LE, et al. Fgd5 identifies hematopoietic stem cells in the murine bone marrow. J Exp Med. 2014;211:1315\u201331.","journal-title":"J Exp Med"},{"key":"7911_CR34","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1016\/j.molcel.2023.10.016","volume":"83","author":"L Crozier","year":"2023","unstructured":"Crozier L, Foy R, Adib R, Kar A, Holt JA, Pareri AU, et al. CDK4\/6 inhibitor-mediated cell overgrowth triggers osmotic and replication stress to promote senescence. Mol Cell. 2023;83:4062\u20134077.e4065.","journal-title":"Mol Cell"},{"key":"7911_CR35","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1016\/j.molcel.2023.10.020","volume":"83","author":"R Foy","year":"2023","unstructured":"Foy R, Crozier L, Pareri AU, Valverde JM, Park BH, Ly T, et al. Oncogenic signals prime cancer cells for toxic cell overgrowth during a G1 cell cycle arrest. Mol Cell. 2023;83:4047\u20134061.e4046.","journal-title":"Mol Cell"},{"key":"7911_CR36","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1016\/j.molcel.2023.10.018","volume":"83","author":"S Manohar","year":"2023","unstructured":"Manohar S, Estrada ME, Uliana F, Vuina K, Alvarez PM, de Bruin RAM, et al. Genome homeostasis defects drive enlarged cells into senescence. Mol Cell. 2023;83:4032\u20134046.e4036.","journal-title":"Mol Cell"},{"key":"7911_CR37","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1016\/j.molcel.2023.10.017","volume":"83","author":"GA Wilson","year":"2023","unstructured":"Wilson GA, Vuina K, Sava G, Huard C, Meneguello L, Coulombe-Huntington J, et al. Active growth signaling promotes senescence and cancer cell sensitivity to CDK7 inhibition. Mol Cell. 2023;83:4078\u20134092.e4076.","journal-title":"Mol Cell"},{"key":"7911_CR38","doi-asserted-by":"publisher","first-page":"44403","DOI":"10.1074\/jbc.M111.289512","volume":"286","author":"JH Lim","year":"2011","unstructured":"Lim JH, Liu Y, Reineke E, Kao HY. Mitogen-activated protein kinase extracellular signal-regulated kinase 2 phosphorylates and promotes Pin1 protein-dependent promyelocytic leukemia protein turnover. J Biol Chem. 2011;286:44403\u201311.","journal-title":"J Biol Chem"},{"key":"7911_CR39","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1126\/science.1183424","volume":"328","author":"XW Zhang","year":"2010","unstructured":"Zhang XW, Yan XJ, Zhou ZR, Yang FF, Wu ZY, Sun HB, et al. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science. 2010;328:240\u20133.","journal-title":"Science"},{"key":"7911_CR40","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1083\/jcb.201305148","volume":"204","author":"U Sahin","year":"2014","unstructured":"Sahin U, Ferhi O, Jeanne M, Benhenda S, Berthier C, Jollivet F, et al. Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins. J Cell Biol. 2014;204:931\u201345.","journal-title":"J Cell Biol"},{"key":"7911_CR41","doi-asserted-by":"crossref","unstructured":"Kovatcheva M, Liao W, Klein ME, Robine N, Geiger H, Crago AM, et al. ATRX is a regulator of therapy induced senescence in human cells. Nat Commun. 2017;8:386.","DOI":"10.1038\/s41467-017-00540-5"},{"key":"7911_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6210","volume":"5","author":"LF Duarte","year":"2014","unstructured":"Duarte LF, Young AR, Wang Z, Wu HA, Panda T, Kou Y, et al. Histone H3.3 and its proteolytically processed form drive a cellular senescence programme. Nat Commun. 2014;5:5210.","journal-title":"Nat Commun"},{"key":"7911_CR43","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1093\/nar\/gkac259","volume":"50","author":"M Udugama","year":"2022","unstructured":"Udugama M, Vinod B, Chan FL, Hii L, Garvie A, Collas P, et al. Histone H3.3 phosphorylation promotes heterochromatin formation by inhibiting H3K9\/K36 histone demethylase. Nucleic Acids Res. 2022;50:4500\u201314.","journal-title":"Nucleic Acids Res"},{"key":"7911_CR44","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1016\/j.clbc.2021.07.013","volume":"22","author":"H Norman","year":"2022","unstructured":"Norman H, Lee KT, Stearns V, Alcorn SR, Mangini NS. Incidence and severity of myelosuppression with palbociclib after palliative bone radiation in advanced breast cancer: a single center experience and review of literature. Clin Breast Cancer. 2022;22:e65\u2013e73.","journal-title":"Clin Breast Cancer"},{"key":"7911_CR45","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.cmet.2020.09.006","volume":"32","author":"S Omori","year":"2020","unstructured":"Omori S, Wang TW, Johmura Y, Kanai T, Nakano Y, Kido T, et al. Generation of a p16 reporter mouse and its use to characterize and target p16(high) cells in vivo. Cell Metab. 2020;32:814\u2013828.e816.","journal-title":"Cell Metab"},{"key":"7911_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03587-x","volume":"12","author":"T Baba","year":"2021","unstructured":"Baba T, Yoshida T, Tanabe Y, Nishimura T, Morishita S, Gotoh N, et al. Cytoplasmic DNA accumulation preferentially triggers cell death of myeloid leukemia cells by interacting with intracellular DNA sensing pathway. Cell Death Dis. 2021;12:322.","journal-title":"Cell Death Dis"},{"key":"7911_CR47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"7911_CR48","doi-asserted-by":"crossref","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform. 2011;12:323.","DOI":"10.1186\/1471-2105-12-323"},{"key":"7911_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"7911_CR50","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357\u20139.","journal-title":"Nat Methods"},{"key":"7911_CR51","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010;38:576\u201389.","journal-title":"Mol Cell"},{"key":"7911_CR52","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.1630","volume":"28","author":"CY McLean","year":"2010","unstructured":"McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, et al. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol. 2010;28:495\u2013501.","journal-title":"Nat Biotechnol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07911-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07911-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07911-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T13:18:22Z","timestamp":1757337502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07911-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,2]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7911"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07911-7","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,2]]},"assertion":[{"value":"1 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. The animal studies were approved by the Committee of Laboratory Animals of Kanazawa University (AP-214222). No studies including human subjects were performed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"586"}}